| Structure |
Chemical Name |
CAS |
MF |
 |
Etoricoxib Impurity 39 |
107825-28-5 |
C13H17NOS2 |
 |
Furosemide Impurity 7 |
4753-68-8 |
C5H8ClNO |
 |
Irinotecan Impurity 24 |
802277-44-7 |
C13H24N2O2 |
 |
Pyridoxine Impurity 12 |
58947-70-9 |
C8H9NO3 |
 |
Thiamine |
6309-04-2 |
C13H20Br2N4OS |
 |
1,1'-(1,4,8,11-tetraazacyclotetradecane-1,4-diyl)bis(2,2,2- trifluoroethan-1-one) dihydrochloride |
|
C14H24Cl2F6N4O2 |
 |
Empagliflozin Impurity 40 |
|
|
|
|
Empagliflozin Impurity 46 |
|
|
![Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester](/CAS/20200119/GIF/153900-96-0.gif) |
Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester |
153900-96-0 |
C27H48O7 |
 |
pranoprofen |
143436-36-6 |
C17H19NO4 |
![2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile](/CAS/20200119/GIF/906673-30-1.gif) |
2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile |
906673-30-1 |
C14H10BNO3 |
 |
Fluconazole Impurity 5 |
154534-83-5 |
C10H9ClF2N4O |
 |
Fexofenadine N-Oxide |
1422515-52-3 |
C32H39NO5 |
 |
Trimetazidine Impurity 16 |
118709-62-9 |
C13H16O4 |
 |
Ortho-Isomer of Dapagliflozin |
2040305-05-1 |
C21H25ClO6 |
 |
Imidafenacin Related Compound 9 |
170105-17-6 |
C21H21N3 |
|
|
Cefminox Sodium impurity 1 |
|
|
|
|
Dapagliflozin Impurity 5 |
|
|
|
|
Emtricitabine Impurity E |
|
|
 |
Furosemide Impurity 4 |
|
C12H11ClN2O5S |
|
|
Pitavastatin Impurity 43 |
|
|
 |
Tazobactam Impurity B |
158411-82-6 |
C6H11NO3S |
|
|
Tirofiban Impurity E |
|
|
|
|
Tofacitinib Impurity 73 |
|
|
![(2R,3R)-2-アミノ-3-[4-(メチルスルホニル)フェニル]-1,3-プロパンジオール](/CAS/GIF/51458-28-7.gif) |
(2R,3R)-2-アミノ-3-[4-(メチルスルホニル)フェニル]-1,3-プロパンジオール |
51458-28-7 |
C10H15NO4S |
 |
21-(アセチルオキシ)-16α,17-ジヒドロキシプレグナ-1,4,9(11)-トリエン-3,20-ジオン |
77017-20-0 |
C23H28O6 |
 |
Pyrimidine, 4-chloro-5-nitro-2-(propylthio)- |
2518331-26-3 |
C7H8ClN3O2S |
|
|
Oseltamivir Impurity 110 |
|
|
|
|
Oseltamivir Impurity 108 |
|
|
|
|
Oseltamivir Impurity 102 |
|
|
 |
1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)- |
2606144-45-8 |
C16H18N6O |
 |
4-Piperidinecarboxylic acid, 1-(4-pyridinylcarbonyl)-, ethyl ester |
252263-38-0 |
C14H18N2O3 |
 |
1,4-ビス(4-ニトロフェニル)ピペラジン |
16264-05-4 |
C16H16N4O4 |
 |
ビス(2,4-キシリル)ペルスルフィド |
13616-83-6 |
C16H18S2 |
 |
バモロロン |
13209-41-1 |
C22H28O4 |
![3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2374700-40-8.gif) |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
2374700-40-8 |
C16H20N6O |
![7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI)](/CAS/20210305/GIF/129815-82-3.gif) |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI) |
129815-82-3 |
C18H20FN3O4 |
![Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]-](/CAS/20210305/GIF/769083-63-8.gif) |
Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]- |
769083-63-8 |
C19H24N2O |
 |
N,N'-ジイソプロピル尿素 |
4128-37-4 |
C7H16N2O |
![Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester](/CAS/20210305/GIF/141354-54-3.gif) |
Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester |
141354-54-3 |
C9H9BrN2O3 |
|
|
monocalcium mono((3R,5S,E)-7-(4-(3-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
 |
Warfarin Impurity 1 |
55901-61-6 |
C13H14O |
 |
Macitentan impurity B |
441796-13-0 |
C18H18Br2N6O4S |
|
|
Meropenem IMP B |
|
|
 |
4-(6-ブロモピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
412348-27-7 |
C14H20BrN3O2 |
![(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180703/GIF/1012341-56-8.gif) |
(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-56-8 |
C23H29NO4 |
 |
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |
 |
Parecoxib Impurity C |
3026677-40-4 |
|
 |
RAC アトモキセチン塩酸塩 |
82857-40-7 |
C17H22ClNO |
 |
3-(1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
943320-48-7 |
C10H8F3N3 |
 |
Linagliptin Impurity H |
1646355-34-1 |
C22H23N7O2 |
 |
Ezetimibe Impurity 54 |
1185883-39-9 |
C40H36F2N2O5 |
 |
2-(2-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
1348664-75-4 |
C13H13FN6O |
|
|
Dapagliflozin Impurity 2 |
|
|
|
|
Cefradine Impurity J |
|
|
|
|
Peramivir diacetyl impurity 1 |
|
|
|
|
Urapidil Impurity 17 |
|
|
|
|
Clindamycin Impurity 86 |
|
|
|
|
Canagliflozin Impurity 77 |
|
|
|
|
Carbazochrome Sodium Sulfonate Impurity I |
|
|
|
|
Tadalafil impurities 45 |
|
|
|
|
Posaconazole Impurities 10 Complete Set |
|
|
|
|
Cetrorelix Impurity 18 |
|
|
|
|
Cetrorelix Impurity 13 |
|
|
|
|
Bortezomib Impurity G Full Set Pre- |
|
|
|
|
Cetrorelix Impurity 2 (+L-Ser) |
|
|
|
|
Peramivir Intermediate Impurity 39 |
|
|
|
|
Peramivir Intermediate Impurity 59 |
|
|
|
|
Criborole impurity 999 |
|
|
|
|
Pemetrexed Disodium Impurity 21-30 |
|
|
|
|
Bimatoprost Impurity 2 |
|
|
 |
Pregna-1,4-dien-3-one, 21-(acetyloxy)-11,17,20-trihydroxy-6-methyl-, (6α,11β)- (9CI) |
151003-82-6 |
C24H34O6 |
![3-[4-(トリフルオロメチル)フェニル]プロパン-1-オール](/CAS/GIF/180635-74-9.gif) |
3-[4-(トリフルオロメチル)フェニル]プロパン-1-オール |
180635-74-9 |
C10H11F3O |
|
|
(1R,2R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
|
|
 |
(E)-2-CYANO-5-METHYL-HEX-2-ENOIC ACID METHYL ESTER |
96914-67-9 |
C9H13NO2 |
|
|
Nicergoline Impurity 7 |
|
|
 |
N,N'-Bis(2-Hydroxyethyl)propane-1,3-diamine |
10563-27-6 |
C7H18N2O2 |
|
|
Imatinib Impurity 1 |
|
|
|
|
Imatinib Impurity 6 |
|
|
 |
Nifedipine Impurity 3 |
|
C19H22N2O6 |
|
|
Riociguat Impurtiy 5 |
|
|
|
|
Vonoprazan Impurity 6 |
|
|
 |
Citalopram EP Impurity E |
64169-47-7 |
C19H22Cl2FNO |
|
|
Dapagliflozin Impurity F |
|
|
|
|
Dapoxetine Impurity A |
|
|
 |
(1R,3S,4S)-エンテカビル |
1333204-94-6 |
C12H15N5O3 |
 |
Gadobutrol Impurity |
71231-87-3 |
C7H15NO5 |
|
|
Pramipexole Impurity G |
|
|
![SALMETEROL RELATED COMPOUND A (4-[1-ヒドロキシ-2-(4-フェニルブチルアミノ)エチル]-2-(ヒドロキシメチル)フェノール)](/CAS/20180703/GIF/1798014-51-3.gif) |
SALMETEROL RELATED COMPOUND A (4-[1-ヒドロキシ-2-(4-フェニルブチルアミノ)エチル]-2-(ヒドロキシメチル)フェノール) |
1798014-51-3 |
C19H25NO3 |
|
|
Tacrolimus impurity D |
|
|
![2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole](/CAS/20180703/GIF/202189-77-3.gif) |
2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole |
202189-77-3 |
C32H44N4O2 |
|
|
Saxagliptin Impurity 6 |
|
|
 |
Ethyl 4-(4-fluorophenyl)-1-methyl-2,6-dioxopiperidine-3-carboxylate |
202534-94-9 |
C15H16FNO4 |
|
|
Tofacitinib Impurity 100 |
|
|
|
|
Vildagliptin Impurity 36 |
|
|
|
|
Butyphthalide impurity 52 |
|
|
 |
Tofacitinib Impurity 102 |
1615709-90-4 |
C14H17ClN2 |
 |
Pralatrexate Impurity 12 |
1451250-74-0 |
C23H23N7O5 |
|
|
Pralatrexate Impurity 17 |
|
|
|
|
Pitavastatin Impurity 49 |
|
|